# Single-dose Study of [14C]PF-05221304 Metabolism and Excretion in Healthy Adult Male Subjects

> **NCT03448172** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C]PF-05221304

## Key facts

- **NCT ID:** NCT03448172
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-18
- **Primary completion:** 2018-05-26
- **Final completion:** 2018-06-13
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03448172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03448172, "Single-dose Study of [14C]PF-05221304 Metabolism and Excretion in Healthy Adult Male Subjects". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03448172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*